Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
BICYCLE THERAPEUTICS plc (BCYC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/05/2023 |
4
| Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 54 shares
@ $20, valued at
$1.1k
|
|
10/05/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 272 shares
@ $20, valued at
$5.4k
|
|
10/05/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
10/05/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
10/05/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 1,470 shares
@ $20, valued at
$29.4k
|
|
10/05/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 442 shares
@ $20, valued at
$8.8k
|
|
07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2023 |
4
| Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 61 shares
@ $25.1, valued at
$1.5k
|
|
07/06/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
07/06/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
07/06/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 1,498 shares
@ $25.1, valued at
$37.6k
|
|
07/06/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 336 shares
@ $25.1, valued at
$8.4k
|
|
07/06/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 451 shares
@ $25.1, valued at
$11.3k
|
|
04/05/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 319 shares
@ $21.11, valued at
$6.7k
|
|
04/05/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 447 shares
@ $21.11, valued at
$9.4k
|
|
04/05/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 447 shares
@ $21.11, valued at
$9.4k
|
|
04/05/2023 |
4
| Kalowski Lee (President and CFO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 376 shares
@ $21.11, valued at
$7.9k
|
|
04/05/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 447 shares
@ $21.11, valued at
$9.4k
|
|
04/05/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Sold 1,486 shares
@ $21.11, valued at
$31.4k
|
|
04/04/2023 |
4
| Arroyo Santiago (Chief Development Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 120,000 options to buy
@ $21.77, valued at
$2.6M
|
|
01/05/2023 |
4
| Jordan Veronica GH (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 5,750 shares
@ $0 Granted 11,500 options to buy
@ $29.6, valued at
$340.4k
|
|
01/05/2023 |
4
| Winter Gregory Paul (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 5,750 shares
@ $0 Granted 11,500 options to buy
@ $29.6, valued at
$340.4k
|
|
01/05/2023 |
4
| Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,801 shares
@ $29.06, valued at
$52.3k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,801 shares
@ $29.06, valued at
$52.3k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Smethurst Dominic (Chief Medical Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,801 shares
@ $29.06, valued at
$52.3k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,801 shares
@ $29.06, valued at
$52.3k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,817 shares
@ $29.06, valued at
$52.8k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Kalowski Lee (President and CFO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 17,500 shares
@ $0 Sold 1,815 shares
@ $29.06, valued at
$52.7k
Granted 35,000 options to buy
@ $29.6, valued at
$1M
|
|
01/05/2023 |
4
| Bourque Janice (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 5,750 shares
@ $0 Granted 11,500 options to buy
@ $29.6, valued at
$340.4k
|
|
01/05/2023 |
4
| Kender Richard N (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 5,750 shares
@ $0 Granted 11,500 options to buy
@ $29.6, valued at
$340.4k
|
|
01/05/2023 |
4
| Gutierrez-Ramos Jose-Carlos (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 5,750 shares
@ $0 Granted 11,500 options to buy
@ $29.6, valued at
$340.4k
|
|
01/05/2023 |
4
| Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 57,500 shares
@ $0 Sold 6,000 shares
@ $29.06, valued at
$174.4k
Granted 115,000 options to buy
@ $29.6, valued at
$3.4M
|
|
01/05/2023 |
4
| Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Granted 11,500 shares
@ $0 Granted 23,000 options to buy
@ $29.6, valued at
$680.8k
|
|
03/29/2022 |
4
| Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns:
| Exercised 5,155 options to buy
@ $20.12, valued at
$103.7k
|
|
|
|
|